Table 3.
Perioperative and post-operative outcomes.
| Data | Total (n=92) |
Group A (n=46) |
Group B (n=46) |
p-Value |
|---|---|---|---|---|
| Operative time, median (IQR), min | 130 (60–300) | 135 (90–212) | 120 (60–300) | 0.132a |
| Blood loss, median (range), mL | 300 (50, 1600) | 300 (100, 1000) | 300 (50, 1600) | 0.780a |
| Admit, median (range), day | 6 (4, 101) | 6 (4, 12) | 6 (4, 101) | 0.224a |
| Drain output, median (range), mL | 182 (0, 3310) | 170 (0, 3310) | 237 (0, 2030) | 0.474a |
| Complication, n (%) | 41 (44.57) | 20 (43.48) | 21 (45.65) | 0.834b |
| Blood transfusion, n (%) | 6 (6.52) | 3 (6.52) | 3 (6.52) | 1.000b |
| Lymph leak, n (%) | 13 (14.13) | 4 (8.70) | 9 (19.57) | 0.135b |
| Fever, n (%) | 21 (22.83) | 12 (26.09) | 9 (19.57) | 0.456b |
| UTI, n (%) | 2 (2.17) | 1 (2.17) | 1 (2.17) | 1.000b |
| Ileus, n (%) | 3 (3.26) | 0 | 3 (6.52) | 0.242b |
| Hematuria, n (%) | 2 (2.17) | 2 (2.17) | 2 (2.17) | 1.000b |
| Intraabdominal collection, n (%) | 1 (1.09) | 1 (2.17) | 0 | 0.999b |
| AUR, n (%) | 1 (1.09) | 0 | 1 (2.17) | 0.999b |
| Scrotal hematoma, n (%) | 1 (1.09) | 1 (2.17) | 0 | 0.999b |
| Stroke, n (%) | 1 (1.09) | 0 | 1 (2.17) | 0.999b |
| Catheterized time, mean±SD, day | 14.52±4.34 | 15.19±4.61 | 13.84±4.00 | 0.138a |
| PSA 3 month, median (range), ng/mL | 0.003 (0.003–1.55) |
0.003 (0.003–1.28) |
0.003 (0.003–1.55) |
0.341a |
AUR, acute urinary retention; UTI, urinary tract infection; PSA, prostate-specific antigen.
a
Student's t-test or Wilcoxon rank-sum test.
b
Chi-square test or Fisher's exact test.